RadNet, Inc.

NasdaqGM:RDNT 주식 보고서

시가총액: US$4.9b

RadNet 과거 수익 실적

과거 기준 확인 2/6

RadNet의 수입은 연평균 -12.2%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 5.4%의 비율로 증가했습니다. 매출은 연평균 9.8%의 비율로 증가해 왔습니다. RadNet의 자기자본이익률은 3.9%이고 순이익률은 0.6%입니다.

주요 정보

-12.2%

수익 성장률

-16.0%

EPS 성장률

Healthcare 산업 성장8.5%
매출 성장률9.8%
자기자본 수익률3.9%
순이익0.6%
다음 실적 업데이트11 Nov 2024

최근 과거 실적 업데이트

Recent updates

Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return

Oct 15
Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return

RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects

Oct 02

Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares

Sep 22
Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares

RadNet: Growth In Operating Earnings Off Very Little Incremental Capital

Aug 24

RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly

Jul 22
RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly

Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

Jun 05
Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

RadNet: Qualified Growth Route, Still Undervalued

Jun 05

Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?

May 10
Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Apr 08
Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Mar 06
RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

Feb 08
Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation

Jan 28

Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

Dec 28
Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

Dec 04
We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

Aug 27
RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

Aug 09
RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

Mar 30
We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

Feb 19
RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet

Dec 12
RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Nov 26
An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Oct 11

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Oct 10
Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

Aug 28

Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

Aug 12
Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance

Aug 09

RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

Jul 01
RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

Jun 17
Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

Is RadNet (NASDAQ:RDNT) A Risky Investment?

May 11
Is RadNet (NASDAQ:RDNT) A Risky Investment?

Estimating The Intrinsic Value Of RadNet, Inc. (NASDAQ:RDNT)

Apr 06
Estimating The Intrinsic Value Of RadNet, Inc. (NASDAQ:RDNT)

수익 및 비용 분석

RadNet 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

NasdaqGM:RDNT 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 241,714101420
31 Mar 241,658211420
31 Dec 231,61731420
30 Sep 231,58041410
30 Jun 231,528-131420
31 Mar 231,479-131730
31 Dec 221,430111440
30 Sep 221,3828920
30 Jun 221,36523610
31 Mar 221,3441800
31 Dec 211,3242500
30 Sep 211,297351080
30 Jun 211,25624550
31 Mar 211,13811810
31 Dec 201,098-1500
30 Sep 201,090-101060
30 Jun 201,091-131080
31 Mar 201,16421330
31 Dec 191,1541500
30 Sep 191,11133240
30 Jun 191,06035990
31 Mar 191,01536900
31 Dec 189753200
30 Sep 18953-4850
30 Jun 18939-6830
31 Mar 18925-6590
31 Dec 17922000
30 Sep 1791211770
30 Jun 179099740
31 Mar 178977750
31 Dec 168857740
30 Sep 168755750
30 Jun 1685911760
31 Mar 1684511740
31 Dec 158108720
30 Sep 1577911700
30 Jun 157557680
31 Mar 157309660
31 Dec 147181640
30 Sep 14710-2630
30 Jun 14701-7630
31 Mar 14699-9640
31 Dec 137032650

양질의 수익: RDNT 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: RDNT 는) 과거에 수익을 냈습니다.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: RDNT 의 수입은 지난 5년 동안 매년 12.2% 씩 감소했습니다.

성장 가속화: RDNT 지난해 흑자를 기록해 5년 평균과 비교하기 어려운 수익 성장률을 보이고 있습니다.

수익 대 산업: RDNT 작년에 수익을 올렸기 때문에 지난 해 수익 성장을 Healthcare 업계( 11.4% )와 비교하기가 어렵습니다.


자기자본 수익률

높은 ROE: RDNT 의 자본 수익률( 3.9% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기